Background
==========

The sequencing and assembly of a horse genome was a great achievement in equine genomics and veterinary medicine because of the broad range of potential applications of this information for improving health and performance and for understanding differences among species \[[@B1]\]. To date, however, only a single genome of a Thoroughbred mare has been sequenced and made publicly available \[[@B1]\]. The current catalog of genetic variants in the equine genome consists of 1,163,580 single nucleotide polymorphisms (SNPs; dbSNP: <http://www.ncbi.nlm.nih.gov/projects/SNP/> \[build 135\]), with no insertion/deletion polymorphisms (INDELs) or copy number variants (CNVs) having been deposited into a publicly available database (dbSNP or dbVar, <http://www.ncbi.nlm.nih.gov/dbvar>). Of the known SNPs in horses, most (\~64%) originate from the Thoroughbred mare used for the genome assembly \[[@B1]\].

Sequencing the genome of a Quarter Horse was considered important for several reasons. Almost 3 million Quarter Horses were registered in the United States in 2010 according to the American Quarter Horse Association, making it the single largest breed registry in the country \[[@B2],[@B3]\]. When one includes non-registered Quarter Horses and other Quarter Horse-influenced breed registries (e.g., American Paint Horse Association), the Quarter Horse is by far the largest contributor to the population of horses in the United States. Although Quarter Horse breeding was, and continues to be, strongly influenced by Thoroughbred bloodlines, the 2 breeds were selectively bred to enhance different traits. Thoroughbred breeding has selected for speed over distances of 3/4 to 2 miles, whereas selection in the Quarter Horse has emphasized speed over shorter distances and compliant disposition suited to working cattle and other ranch-related duties \[[@B4]\]. Thus, there are important phenotypic differences between the breeds that have been achieved by selective breeding with a clear underlying genetic component \[[@B5],[@B6]\]. Moreover, there are single-gene disorders in Quarter Horses, such as polysaccharide storage myopathy (PSSM) \[[@B7],[@B8]\], hyperkalemic periodic paralysis (HYPP) \[[@B9]\], glycogen branching enzyme deficiency (GBED) \[[@B10]\], and hereditary equine regional dermal asthenia (HERDA) \[[@B11],[@B12]\]. Most diseases and traits (such as predisposition to osteoarthritis or body-type) are complex, involving multiple genes, which may be modulated by environmental factors \[[@B5],[@B13],[@B14]\]. Thus, identifying genetic variants in the genome of a single Quarter Horse would provide a wealth of information for future genomic studies in equids.

Here we describe the whole-genome sequencing of an individual Quarter Horse mare using massively parallel paired-end sequencing. Sequence reads were mapped to the reference Thoroughbred nuclear and mitochondrial genomes. We developed a comprehensive list of genetic variants, including SNPs, INDELs, and CNVs. We annotated genetic variants and examined their impact on gene structure and function. The genomic sequence was also examined for mutations and polymorphisms associated with diseases and traits in horses. Furthermore, we examined biological processes enriched for genetic variants and compared these biological processes between this Quarter Horse mare and the reference Thoroughbred mare.

Results
=======

Whole-genome sequencing, alignment, and identification of new genomic sequence
------------------------------------------------------------------------------

Genomic DNA was obtained from a single blood sample of a Quarter Horse mare owned by Texas A&M University. The mare\'s pedigree was heavily influenced by stock and racing Quarter Horses, with no introgression of Thoroughbred lines during the preceding 4 generations. A small insert library with an average size of approximately 270 base-pair (bp) was generated (Additional file [1](#S1){ref-type="supplementary-material"}, **Figure S1**), and 14 lanes of 75-bp paired-end sequencing were performed using the Illumina Genome Analyzer II (Additional file [2](#S2){ref-type="supplementary-material"}, **Table S1**) (Illumina, Inc., San Diego, CA). A schematic of the sequence mapping and variant identification, annotation, and analysis is presented in Figure [1](#F1){ref-type="fig"}. The sequencing reactions yielded 849,600,742 reads totaling 61,310,282,925 bases of DNA (Additional file [3](#S3){ref-type="supplementary-material"}, **Table S2)**. Sequence reads were trimmed and mapped to the assembled autosomes, × chromosome, and mitochondrial genome of the reference Thoroughbred horse genome (EquCab2.0). A total of 817,470,439 reads (59,643,456,282 bases) were aligned to approximately 97% of the reference genome (53,783,377,648 bases were uniquely mapped), resulting in an average of 24.7X sequence coverage of the horse\'s genome (Additional file [3](#S3){ref-type="supplementary-material"}, **Table S2)**. Sequence coverage of assembled chromosomes ranged from 13X to 55X (Additional file [4](#S4){ref-type="supplementary-material"}, **Figure S2**). Additionally, 81,993 reads mapped to 100% of the reference mitochondrial genome, resulting in an average of 355.6X sequence coverage. Reads not mapping to assembled chromosomes were subsequently mapped to the unassembled chromosomes (ChrUn), where 12,865,623 reads (935,090,584 bases) were mapped. Next, we *de novo*assembled 12,657,236 reads (707,253,380 bases) not mapping to the assembled or unassembled chromosomes. The *de novo*assembly yielded 35,540 contigs totaling 19.1 million bases (Mb) of sequence (Table [1](#T1){ref-type="table"}). BLAT and BLAST analysis of the contigs to other genomes did not result in any significant alignment.

![**Overview of genome-wide variation analysis pipeline by next generation sequencing**.](1471-2164-13-78-1){#F1}

###### 

Sequence generation and mapping to equCab2 reference genome

  Method   Lanes   Reads         Bases Mapped (Gb)   Average Depth of Coverage   \% of Reference Mapped   Bases Mapped to ChrUn (Mb)   *De Novo*Assembly of Unmapped (Mb)
  -------- ------- ------------- ------------------- --------------------------- ------------------------ ---------------------------- ------------------------------------
  75 PE    14      817,470,439   59.6                24.7 X                      97%                      935.1                        19.1

Identification of genetic variants
----------------------------------

We analyzed sequences mapped to the assembled chromosomes for putative SNPs, INDELs, and CNVs. SNPs were required to meet several stringent criteria (see **Materials and Methods**) and were further filtered to remove those near other variants (i.e., SNPs and INDELs) or within the pseudo-autosomal region (PAR) of the × chromosome. The resulting SNPs were then filtered using different minimum read-depths (5X and 10X \[Additional file [5](#S5){ref-type="supplementary-material"}, **Table S3 and**Additional file [6](#S6){ref-type="supplementary-material"}, **Table S4\]**). As expected, increasing the minimum read-depth resulted in fewer SNPs being detected (1,131,519 SNPs lost from 5X to 10X coverage; Additional file [7](#S7){ref-type="supplementary-material"}, **Table S5 and**Additional file [8](#S8){ref-type="supplementary-material"}, **Figure S3A and B**). Additionally, we found that a greater proportion of the total SNPs was lost than that of the total non-synonymous SNPs, with homozygous SNPs being lost at the highest rate (Additional file [8](#S8){ref-type="supplementary-material"}, **Figure S3C and D**). At 10X coverage, which was the minimum read-depth used for the subsequent annotation and downstream analysis, we identified 3,157,093 SNPs. Additionally, we characterized and annotated SNPs detected at lower minimum read-depths (Additional files [9](#S9){ref-type="supplementary-material"}, [10](#S10){ref-type="supplementary-material"}, [11](#S11){ref-type="supplementary-material"}, [12](#S12){ref-type="supplementary-material"}, [13](#S13){ref-type="supplementary-material"}, [14](#S14){ref-type="supplementary-material"}, [15](#S15){ref-type="supplementary-material"}, [16](#S16){ref-type="supplementary-material"}, [17](#S17){ref-type="supplementary-material"}, [18](#S18){ref-type="supplementary-material"}, [19](#S19){ref-type="supplementary-material"}, [20](#S20){ref-type="supplementary-material"}, [21](#S21){ref-type="supplementary-material"}, [22](#S22){ref-type="supplementary-material"}, and [23](#S23){ref-type="supplementary-material"}, **Tables S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, and S20)**. Intergenic SNPs, located within 1,000 bases (1 kb) upstream or downstream of a gene, were determined as well as genic SNPs located within introns, non-coding exons, 5\' and 3\' untranslated regions (UTR), intron and exon splice sites, and coding exons. Non-synonymous SNPs were further annotated as either radical or conservative (Table [2](#T2){ref-type="table"}, **and**Additional files [9](#S9){ref-type="supplementary-material"}, [10](#S10){ref-type="supplementary-material"}, [11](#S11){ref-type="supplementary-material"}, [12](#S12){ref-type="supplementary-material"}, [13](#S13){ref-type="supplementary-material"}, [14](#S14){ref-type="supplementary-material"}, [15](#S15){ref-type="supplementary-material"}, [16](#S16){ref-type="supplementary-material"}, [17](#S17){ref-type="supplementary-material"}, [18](#S18){ref-type="supplementary-material"}, [19](#S19){ref-type="supplementary-material"}, [20](#S20){ref-type="supplementary-material"}, [21](#S21){ref-type="supplementary-material"}, [22](#S22){ref-type="supplementary-material"}, and [23](#S23){ref-type="supplementary-material"}, **Tables S6, S7, S8, S9, S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, and S20**; see **Materials and Methods**for description of amino acid classification). Additionally, we identified SNPs located within the coding exons of 305 candidate imprinted genes for future studies in the horse (\[[@B15]\]; Additional file [24](#S24){ref-type="supplementary-material"}, **Table S21**). Analysis of the mitochondrial genome identified 71 SNPs, including 5 heteroplasmic SNPs (Additional file [5](#S5){ref-type="supplementary-material"}, **Table S3 and**Additional file [6](#S6){ref-type="supplementary-material"}, **Table S4**).

###### 

Annotation of SNPs in the Quarter Horse genome

                                           Total       Homozygous   Heterozygous   Novel       Ensembl Genes
  ---------------------------------------- ----------- ------------ -------------- ----------- ------------------------
  **All SNPs**                             3,157,093   1,293,374    1,863,719      2,814,367   24,023
   **Intergenic**                          2,224,292   908,169      1,316,123      1,991,041   19,644
   **Intergenic (Upstream w/in 1 kb)**     40,948      19,241       21,707         37,566      12,803
   **Intergenic (Downstream w/in 1 kb)**   31,901      13,327       18,574         28,494      10,580
   **Intergenic (Up/Down w/in 1 kb)**      929         427          502            866         399
   **Genic**                               859,023     352,210      506,813        756,400     19,414
    **Intron**                             811,204     332,455      478,749        712,764     14,778
    **Non-Coding Exon**                    5,935       2,019        3,916          5,575       2,123
    **5\' UTR**                            1,734       1,014        720            1,630       1,049
    **3\' UTR**                            1,821       780          1,041          1,594       1,184
    **Intron Splice Site**                 300         185          115            280         276
    **Exon Splice Site**                   657         320          337            593         595
    **Coding Exon**                        37,372      15,437       21,935         33,964      10,485 (305 imprinted)
     **Synonymous**                        19,667      7,626        12,041         17,699      7,982
     **Stop Gain**                         214         50           164            206         190
     **Stop Loss**                         8           5            3              7           8
     **Non-Synonymous**                    18,140      8,076        10,064         16,645      6,899

Comparison of putative SNPs in the mapped sequences to the horse SNP database (dbSNP, <http://www.ncbi.nlm.nih.gov/projects/SNP/>) revealed that 342,726 were known and 2,814,367 were novel, including 18,140 non-synonymous SNPs (11,434 radical and 6,706 conservative) and 2,629 complex (i.e., tri-allelic) SNPs. Comparison of the putative SNPs to those identified in the sequencing and assembly of the reference Thoroughbred genome revealed that 244,669 SNPs were overlapping between the 2 horses, including 174,682 intergenic and 69,987 genic SNPs. By removing overlapping known SNPs, we found that the Quarter Horse and Thoroughbred genomes had 2,912,424 and 522,610 unique SNPs, respectively.

Using a minimum read-depth of 10X and similar filtering methods described for the SNP analysis, we identified 193,271 INDELs (1-8 bp insertion or deletions; Table [3](#T3){ref-type="table"}**and**Additional file [25](#S25){ref-type="supplementary-material"}, **Table S22**). Additionally, we identified and annotated INDELs using lower read-depth coverage (5X; Additional file [26](#S26){ref-type="supplementary-material"}, **Table S23**). Although our analysis was limited to INDELs no greater than 8 bp, the overwhelming majority were single bp gains and losses (Additional file [27](#S27){ref-type="supplementary-material"}, **Figure S4**). Of the INDELs identified, 2,574 caused a frameshift mutation (frameshift deletion + insertions) in a coding exon, whereas 35 did not (Table [3](#T3){ref-type="table"}). In addition, 21 INDELs lead to the creation of a stop codon (stop - gain). Given the high number of INDELs affecting coding exons, particularly the large number of homozygous INDELs, we annotated them using the RefSeq annotation. The analysis revealed that 50 RefSeq genes contained INDELs, including 7 genes with loss of a stop codon and 47 with a frameshift.

###### 

Annotation of INDELs in the Quarter Horse genome

  INDEL Location                          Total     Homozygous   Heterozygous
  --------------------------------------- --------- ------------ --------------
  **INDELs (1 bp - 8 bp)**                193,271   127,173      66,098
  **Intergenic**                          122,571   78,538       44,033
  **Intergenic (Upstream w/in 1 kb)**     5,900     5,073        827
  **Intergenic (Downstream w/in 1 kb)**   2,557     1,853        704
  **Intergenic (Up/Down w/in 1 kb)**      126       105          21
  **Genic**                               62,117    41,604       20,513
                                                                 
  **Intron**                              57,618    37,377       20,241
  **Non-Coding Exon**                     277       239          38
  **5\' UTR**                             594       557          37
  **3\' UTR**                             249       195          54
  **Intron Splice Site**                  749       735          14
  **Exon Splice Site**                    771       762          9
  **Coding Exon**                         1,859     1,739        120
                                                                 
  **Frameshift Deletion**                 1,594     1,533        61
  **Frameshift Insertion**                980       940          40
  **Non-Frameshift Deletion**             23        4            19
  **Non-Frameshift Insertion**            12        5            7
  **Stop - Gain**                         21        19           2

Copy number variants (CNVs) were identified using a read-depth algorithm that corrects for GC bias. CNVs were then filtered to remove those within telomeric regions, as investigation of these regions is associated with high false discovery rates \[[@B16]\]. The filtered analysis revealed 282 CNVs, including 274 gains, 6 losses, and 2 homozygous deletions (Additional file [28](#S28){ref-type="supplementary-material"}, **Table S24**, Additional file [29](#S29){ref-type="supplementary-material"}, **Figure S5 and**Additional file [30](#S30){ref-type="supplementary-material"}, **Figure S6**). The sizes ranged from 3.74 kb to 4.84 Mb, with an average length of 296.1 kb. Annotation of the CNVs indicated that 192 and 90 were genic and intergenic, respectively.

Pathway, trait, and disease analysis of identified genetic variants
-------------------------------------------------------------------

We performed a functional annotation clustering analysis of genes containing SNPs, INDELs, and CNVs to identify biological processes (BP) enriched for these classes of genetic variants. Using the horse Ensembl gene identification (ID) for the functional annotation clustering, we found that only a small percentage of BP terms were returned (0.6%). Therefore, we decided to perform the analysis using the human orthologs of horse genes found to possess genetic variants. Of the 6,899 genes containing non-synonymous SNPs, 5,712 had human orthologs and 3,880 returned BP terms (67.9%). Clustering analysis indicated that non-synonymous SNPs were enriched (P \< 0.05) in pathways for sensory perception (27%; P = 3.9 × 10^-15^), cellular processes (24%; P = 1.7 × 10^-6^), and signal transduction (16% P = 2.7 × 10^-7^; Figure [2A](#F2){ref-type="fig"} and Additional file [31](#S31){ref-type="supplementary-material"}, **Table S25**). Separate functional enrichment analysis of genes with either radical or conservative non-synonymous SNPs revealed that the biological processes of the enriched pathways remained unchanged, although there was an increase in enrichment of conservative amino acid changes in the immunity and defense pathway (3% radical and 14% conservative; Additional file [32](#S32){ref-type="supplementary-material"}, **Figure S7A and B**). Clustering analysis of INDELs indicated that genes containing variants were enriched in pathways for signal transduction (26%; P = 4.2 × 10^-6^), developmental processes (15%; P = 3.5 × 10^-10^), and cellular processes (14%; P = 1.4 × 10^-5^; Figure [2B](#F2){ref-type="fig"}). Analysis of CNVs indicated that genes containing variants were enriched in pathways for sensory perception (60%; P = 2.1 × 10^-61^), immunity and defense (19%; P = 2.7 × 10^-2^), and signal transduction (13%; P = 1.3 × 10^-3^; Figure [2C](#F2){ref-type="fig"}).

![**Biological process enrichment analysis of identified genetic variants**. (A) BP enrichment analysis of non-synonymous coding SNPs, (B) INDELs, and (C) CNVs.](1471-2164-13-78-2){#F2}

Comparison of biological pathways containing heterozygous non-synonymous SNPs between the Quarter Horse and reference Thoroughbred (Additional file [33](#S33){ref-type="supplementary-material"}, **Table S26)**revealed that the Quarter Horse had SNPs enriched in pathways for sensory perception (36%; P = 1.3 × 10^-36^), cellular processes (18%; P = 4.8 × 10^-5^), and signal transduction (16%; P = 1.2 × 10^-3^; Additional file [34](#S34){ref-type="supplementary-material"}, **Figure S8A**), whereas the Thoroughbred had SNPs enriched in pathways for immunity and defense (36%; P = 5.2 × 10^-8^), sensory perception (23%; P = 6.4 × 10^-14^), and cellular processes (13%; P = 2.7 × 10^-1^; Additional file [34](#S34){ref-type="supplementary-material"}, **Figure S8B**). As the enrichment analysis reflected percentages of genes within pathways, and because the Quarter Horse contained nearly three times as many heterozygous SNPs as the Thoroughbred, we determined the total number of genes for each BP term that contained a non-synonymous heterozygous SNP. As expected, the Quarter Horse had more genes containing SNPs for each BP class, except for the immune and defense (P = 2.4 × 10^-27^) and nucleic acid metabolism (P = 1.1 × 10^-11^) pathways (Additional file [34](#S34){ref-type="supplementary-material"}, **Figure S8C**, Additional file [35](#S35){ref-type="supplementary-material"}, **Tables S27 and**Additional file [36](#S36){ref-type="supplementary-material"}, **Table S28**).

Next, we investigated the DNA sequence of the Quarter Horse mare for mutations of known diseases and for SNPs associated with various traits in horses (Table [4](#T4){ref-type="table"}). We found the Quarter Horse to be heterozygous for a c.115G \> A mutation in the cyclophilin B (*PPIB*) gene, which causes hereditary equine regional dermal asthenia (HERDA)\[[@B12]\], heterozygous for the g.901C \> T SNP associated with chestnut coat color \[[@B17]\], and homozygous for the g.66493737C \> T and g.22684390C \> T SNPs associated with racing endurance in Thoroughbred horses \[[@B18],[@B19]\]. No other mutations or polymorphisms underlying known diseases or traits were identified.

###### 

Analysis of genetic variants for known traits and diseases

  PMID                  Chromosome   Coordinate              Gene        Gene Name                                         Phenotype                                                            Associated Genotype   QH Genotype
  --------------------- ------------ ----------------------- ----------- ------------------------------------------------- -------------------------------------------------------------------- --------------------- -------------
  20353955 \[[@B32]\]   1            108,249,293             *TRPM1*     transient receptor potential cation channel       Leopard complex spotting and congenital stationary night blindness   C/C C/T               T/T
  17498917 \[[@B12]\]   1            128,056,148             *PPIB*      peptidyl-prolyl cis-trans isomerase B             Hereditary equine regional dermal asthenia                           A/A                   G/**A**
  20419149 \[[@B33]\]   1            138,235,715             *MYO5A*     myosin-Va isoform 1                               Lavender foal syndrome                                               Del 1 bp              Neg
  8995760 \[[@B34]\]    3            36,259,552              *MC1R*      melanocyte-stimulating hormone receptor           Chestnut coat color                                                  T/T                   C/**T**
  11086549 \[[@B17]\]   3            36,259,554              *MC1R*      melanocyte-stimulating hormone receptor           Chestnut coat color                                                  A/A                   G/G
  16284805 \[[@B35]\]   3            77,735,520              *KIT*       mast/stem cell growth factor receptor             Sabino spotting                                                      A/A A/T               T/T
  18253033 \[[@B36]\]   3            77,740,163              *KIT*       mast/stem cell growth factor receptor             Tobiano spotting pattern                                             A/A A/G               G/G
  21070277 \[[@B6]\]    4            38,969,307              *PDK4*      pyruvate dehydrogenase kinase isozyme 4           Racing performance                                                   A/A A/C               C/C
  21070277 \[[@B6]\]    4            38,973,231              *PDK4*      pyruvate dehydrogenase kinase isozyme 4           Racing performance                                                   A/A A/G               G/G
  12230513 \[[@B37]\]   5            20,256,789              *LAMC2*     laminin subunit gamma-2 precursor                 Junctional epidermolysis bullosa                                     Ins C                 Neg
  17029645 \[[@B38]\]   6            73,665,304              *PMEL17*    melanocyte protein 17 precursor                   Silver coat color                                                    T/T T/C               C/C
  19016681 \[[@B39]\]   8            45,603,643-45,610,231   *LAMA3*     laminin alpha-3                                   Junctional epidermolysis bullosa                                     Del 6,589             Neg
  9103416 \[[@B40]\]    9            35,528,429              *DNAPK*     DNA-dependent protein kinase catalytic subunit    Severe combined immunodeficiency                                     Del 5 bp              Neg
  15318347 \[[@B41]\]   10           9,554,699               *RYR1*      ryanodine receptor 1 isoform 2                    Malignant hyperthermia                                               G/G G/C               C/C
  21059062 \[[@B19]\]   10           15,884,567              *CKM*       creatine kinase M-type                            Racing performance                                                   A/A A/G               G/G
  18358695 \[[@B7]\]    10           18,940,324              *GYS1*      glycogen \[starch\] synthase muscle               Polysaccharide storage myopathy                                      A/A A/G               G/G
  7623088 \[[@B42]\]    11           15,500,439              *SCN4A*     sodium channel protein type 4 subunit alpha       Equine hyperkalemic periodic paralysis                               G/G G/C               C/C
  18802473 \[[@B43]\]   14           26,701,092              *SLC36A1*   proton-coupled amino acid transporter 1           Champagne dilution                                                   C/C C/G               G/G
  9580670 \[[@B44]\]    17           50,624,658              *EDNRB*     endothelin B receptor precursor                   Lethal white foal syndrome                                           AG/AG                 TC/TC
  20932346 \[[@B18]\]   18           66,493,737              *MSTN*      growth/differentiation factor 8 precursor         Optimum racing distance                                              T/T                   **T/T**
  12605854 \[[@B45]\]   21           30,666,626              *SLC45A2*   membrane-associated transporter protein isoform   Cream coat color                                                     A/A A/G               G/G
  21059062 \[[@B19]\]   22           22,684,390              *COX4I2*    cytochrome c oxidase subunit 4 isoform 2          Racing performance                                                   T/T T/C               **T/T**
  11353392 \[[@B46]\]   22           25,168,567              *ASIP*      agouti-signaling protein precursor                Black and bay color                                                  Del 11 bp             ND
  18641652 \[[@B47]\]   25           6,574,013-6,581,600     *STX17*     syntaxin 17                                       Gray coat color                                                      Dup 4,600             Neg

Abbreviations: Del, Deletion; Ins, Insertion; Neg, Negative; ND, Not Determined; Dup, Duplication

Discussion
==========

The current catalog of equine genetic variants is limited and primarily consists of those detected from the sequencing and assembly of a single Thoroughbred horse \[[@B1]\]. In the present study, we describe the whole-genome sequencing and identification of genetic variants in the genome of a Quarter Horse mare. To our knowledge, this is the first published report of a whole-genome sequence of a Quarter Horse and the only horse genome sequenced by next-generation sequencing. At 25X sequence coverage, we estimated that approximately 85-88% of the horse\'s genome could be genotyped \[[@B20]\]. Our analysis yielded 3.1 million SNPs, 193 thousand INDELs, and 282 CNVs. Despite the fact that approximately 10% of the novel homozygous SNPs likely reflect errors in the reference genome (given that the accuracy of the reference genome is 99.99%) and that our false discovery rate (FDR) for SNP detection is approximately 1.5% (Doan et al. unpublished studies), the genetic variants identified here represent a significant addition to what is currently available for studies in horses. It should be noted that the breeding structure of Quarter Horses and Thoroughbreds, as well as the differences in sequencing technology (i.e., next-generation sequencing of DNA fragments vs. Sanger sequencing of bacterial artificial clones) most likely contributed to the increased amount of genetic variation identified in this study. We suspect that many genetic variants were missed due to the parameters applied during our variant detection (e.g., requiring a minimum of 10X sequence coverage). To minimize this false negative rate (FNR) we provide a list of SNPs and INDELs using a less stringent calling criterion (5X minimum sequence coverage; Additional file [5](#S5){ref-type="supplementary-material"}, **Table S3**). However, caution should be used with these variants as the FDR is expected to increase with a reduced minimum coverage, although not directly proportional to the decrease of the FNR.

*De novo*assembly of reads not mapping to the assembled or un-assembled chromosomes led to the generation of 19.1 Mb of new horse genomic sequence. Our analysis of CNVs in horses and cattle using array comparative genomic hybridization (Doan et al., unpublished studies), as well as studies in the human and mouse show that large (Mb) deletions are common variants in the genome \[[@B21]-[@B24]\]. This presence/absence variation \[[@B25]\] is common, and thus we suspect that some percentage of the *de novo*assembled sequence represents sequence missing from the reference Thoroughbred genome due to homozygous deletions.

Functional annotation clustering analysis of genetic variants revealed that pathways for sensory perception, signal transduction, protein processing, cellular process, and immunity and defense were differentially affected by each type of genetic variant (i.e., SNPs, INDELs, and CNVs), suggesting varying degrees of tolerance and selection for genetic variants underlying these biological processes. Genes involved in sensory perception pathways contained most of the genetic variation, primarily SNPs (27%) and CNVs (60%). The observed enrichment in sensory perception genes may be related to selection of the Quarter Horse for a relatively calm disposition \[[@B26],[@B27]\], although this is highly speculative at this point, and will only be determined by future population based-studies. Conversely, these variants could reflect misassemblies in the reference genome or misalignments in the Quarter Horse reads to the reference sequence, as these genes exist as large families with numerous pseudogenes.

Conclusions
===========

This is the first sequencing of a horse genome by next-generation sequencing and the first genomic sequence of an individual Quarter Horse. The genetic variants identified in this study will be a useful resource for future studies to understand the genetic basis of phenotypic variation and disease in equids.

Methods
=======

DNA sample
----------

DNA was isolated from whole blood of a Quarter Horse mare using a standard phenol-chloroform extraction including 2 phenol-chloroform-isoamyl (PCI) steps, followed by rinses with chloroform, isopropanol, and 70% ethanol. The sample was suspended in Qiagen EB buffer (Qiagen Sciences, Germantown, MD). The Texas A&M University Institutional Animal Care and Use Committee approved this study.

Whole-genome sequencing
-----------------------

For the construction of sequencing libraries, we first sonicated high-quality genomic DNA by pulsing 3X for 15 sec/pulse at 14% using a Sonic Dismembrator 500 (Fisher Scientific, Pittsburg, PA) and purified with an Invitrogen PureLink PCR Kit (Invitrogen, Carlsbad, CA). The DNA was blunt end-repaired, adenylated, and ligated with paired-end adaptors, according to the manufacturer\'s protocol (Illumina, San Diego CA). The prepared library was resolved on a 2% low range agarose gel and a 2-mm section of DNA was isolated at 271 bp (Qiagen Sciences, Germantown, MD). The library was then enriched according to the manufacturer\'s protocol (Illumina, San Diego CA). The size and concentration of the sequencing library was determined by PCR, visualization of polyacrylamide gel electrophoresis (PAGE) gels, and through the use of the Agilent 2100 Bioanalyzer DNA kit (Agilent Technologies, San Diego CA). Cluster generation and paired-end sequencing was performed according to the manufacturer\'s protocols (Illumina) at the AgriLife Genomics and Bioinformatics Center (College Station, TX)

Sequence alignment
------------------

We used the trim function in the CLC Genomics Workbench (CLC Bio, Aarhus, Denmark) using the following parameters: ambiguous limit, 2; ambiguous trim, yes; quality limit, 0.1; quality trim, yes; and, remove 3\' nucleotide, no; remove 5\' nucleotide, no. The CLC Genomics Workbench Reference Mapping function was used to assemble the trimmed reads to the equCab2 reference assembly using the following parameters: similarity score = 0.8; and, length fraction = 0.5. Paired-end reads were mapped using an insert range of 180-bp to 500-bp and reads mapping to multiple places in the reference were mapped using the random setting. In order to determine the percent of the genome that was mapped by uniquely mapped read, we used the previously stated settings with nonspecific reads being ignored.

SNP detection
-------------

We used the SNP detection function in CLC Genomics Workbench, based on the neighborhood quality standard (NQS) algorithm, using the following parameters: minimum coverage = 5; minimum central base quality = 30; average base quality over a window length of 11 nucleotides = 15; and, minimum allele frequency = 35%. SNPs were filtered by removing those within 10 bp of another variant (both INDELs and SNPs). Also, SNPs located within the pseudo-autosomal region (PAR) were removed \[[@B28]\]. The remaining SNPs were filtered by read-depth to create SNP analyses with minimum depths of 5, 6, 7, 8, 9, and 10.

INDEL detection
---------------

We used the deletion and insertion polymorphism (DIP) function in CLC Genomics Workbench using the following parameters: minimum coverage = 5; minimum allele frequency = 35%; and, maximum expected variations = 2. INDELs were filtered in a similar manner as SNPs, with those near other variants and within the PAR being removed. Analyses were conducted at both 5X and 10X read-depths.

CNV detection
-------------

We used the Control-FREE copy number algorithm (FREEC) program to identify CNVs in the mapped sequence data \[[@B16]\]. We optimized the program for our data using a break-point threshold of -0.0013 and a coefficient of variation of 0.045. Additionally, we removed any CNVs located within 1 Mb of the beginning and end of all chromosomes in order to reduce the potential for erroneous calling.

Genetic variant annotation and analysis
---------------------------------------

We re-annotated the variant calls from CLC Genomics using both Galaxy <http://galaxy.psu.edu/> and ANNOVAR software programs \[[@B29],[@B30]\]. The join and merge functions in Galaxy were used to annotate the SNPs and INDELs. We used these functions to compare the SNPs to all known SNPs in dbSNP as well as those identified in the reference horse. The ANNOVAR program used the Ensembl annotation database to create an mRNA library, allowing for the determination of amino acid changes. The program was used to determine the locations of all variants within the genome. We also annotated the known SNPs from the reference Thoroughbred genome to determine amino acid changes as well as gene locations for a comparison to the Quarter Horse. The SNPs were divided into groups based on radical and conservative amino acid changes, where radical SNPs result in a difference in polarity or charge when the amino acid was changed while conservative SNPs cause no change in polarity or charge.

The gene lists for each group were converted to human Ensembl gene IDs using Ensembl Biomart. Biological function analysis was performed through the DAVID Functional Annotation Tool, using the default settings \[[@B31]\]. The resulting biological process terms were further grouped by similarities in function to determine enrichment for specific biological processes (Additional file [37](#S37){ref-type="supplementary-material"}, **Table S29**). Statistical significance (p-value) for each enriched group was determined using Fisher\'s combined probability test with the p-value created from the DAVID Functional Annotation Tool. The enriched genes for each biological process group were compared between the Quarter Horse and reference Thoroughbred using the Fisher\'s exact test for a 2 × 2 contingency table.

Analysis of *de novo*assembly of unmapped reads
-----------------------------------------------

We created a *de novo*assembly of all reads that did not align to the reference genome (including ChrMt and ChrUn) using de Bruijn Graphs (CLC Genomics). We were able to assemble 8,186,040 of the 12,657,236 unmapped reads into contigs with minimum and average contig lengths of 200 bp and 537 bp, respectively. We performed *de novo*assembly of reads not mapping to either assembled or unassembled chromosomes using the following parameters: similarity = 0.8; length fraction = 0.5; insertion cost = 3; deletion cost = 3; mismatch cost = 3; minimum paired distance = 180 bp; and, maximum paired distance = 500 bp. The resulting 35,540 contigs were further analyzed by BLAST, mapping all complete genomes and chromosomes from RefSeq.

Sequence data and genetic variants
----------------------------------

The Illumina FASTQ data generated from this study has been submitted to the NCBI Sequence Read Archive <http://www.ncbi.nlm.nih.gov/sra> under accession number SRX110702. The mapped sequences and genetic variants have been submitted to Intrepid Bioinformatics and are available for public viewing <http://server1.intrepidbio.com/FeatureBrowser/ngsdatasetrecord/record?ngsrecord=6197673305>. A complete list of SNPs, INDELs, and CNVs are listed in Additional files [5](#S5){ref-type="supplementary-material"}, [6](#S6){ref-type="supplementary-material"}, and [24](#S24){ref-type="supplementary-material"}, Tables S3, S4 and S24.
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